Dissertação Final - Hospital Veterinário do Baixo Vouga

Referências bibliográficas
• Saba CF, Hafeman SD, Vail DM and Thamm DH. 2009. Combination Chemotherapy
with Continuous L-Asparaginase, Lomustine, and Prednisone for Relapsed Canine
Lymphoma. Vet Intern Med 23:1058–1063;
• Sedlacek HS, Ramsey DS, Boucher JF, Eagleson JS, Conder GA, Clemence RG. 2008.
Comparative efficacy of maropitant and selected drugs in preventing emesis induced by
centrally or peripherally acting emetogens in dogs. J Vet Pharmacol Therap 31, 533–537;
• Simon D, Moreno SN, Hirschberger J. 2008. Efficacy of a continuous, multiagent
chemotherapeutic protocol versus a short-term single-agent protocol in dogs with
lymphoma. J Am Ver Med Ass 232:879-885;
• Simon D, Nolte I, Eberle N. 2006. Treatment of dogs with lymphoma using a 12-week,
maintenance-free combination chemotherapy protocol. J Vet Intern Med 20:948–954.
• Spodnick GJ, Berg J, Rand WM, Schelling SH, Couto G, Harvey HJ, Henderson
RA, MacEwen G, Mauldin N, McCaw DL. 1992. Prognosis for dogs with appendicular
osteosarcoma treated by amputation alone: 162 cases (1978–1988). J Am Vet Med Assoc
200:995–999;
• Stenberg P, Macdonald TP, Jackson CW. 1995. Disruption of microtubules in vivo by
vincristine induces large membrane complexes and other cytoplasmatic abnormalities in
megakaryocytes and platelets of normal rats like those in human and Wistar Furth rat
hereditary macrothrombocytopenias. Journal of Cellular Physiology 162: 86–102.
• Stevenson S, Holm RB, Pohler OE. 1982. Fracture-associated sarcoma in the dog. J Am
Vet Med Assoc 180:1189;
• Straw RC, Withrow SJ, Richter SL. 1991. Amputation and cisplatin for treatment of
canine osteosarcoma. J Vet Intern Med 5:205–210;
• Straw RC. 1996. Tumors of the skeletal system. In: Withrow SJ, MacEwen EG: Small
animal clinical oncology. 2.ed. Philadelphia: WB Saunders; p.287-315;
• Vail DM, MacEwan EG, Young KM. 2001.Canine lymphoma and lymphoid leukemias.
In: withrow S.J. Small Animal Clinical Oncology; 3 rd Edition, Philadelphia: Saunders;
• Vail DM, Rodabaugh HS, Conder GA, Boucher JF and Mathur S. 2007. Efficacy of
injectable maropitant (Cerenia TM ) in a randomized clinical trial for prevention and
treatment of cisplatininduced emesis in dogs presented as veterinary patients; Pfizer, Inc.
Journal compilation Blackwell Publishing Ltd;
• Vail DM. 2003. Lymphoproliferative and myeloprolierative disorders; in: BSAVA
Manual of canine and feline Oncology; 2 nd edition;
60